Caprion

Revealing Differences in the Proteome

Biomarker Discovery

Caprion is the leader in proteomic biomarker discovery.

  • Translational research
  • Pharmacodynamics, MOA, drug response
  • Predictive outcome and patient stratification
  • Companion diagnostics

Learn more

MRM Assays

Translate your discoveries into clinic with Caprion MRM assays.

  • Multiplexed assays
  • Cost-effective alternative to immunoassays
  • Custom biomarker panels
  • Validation for genomics and biomarker discovery

Learn more

Custom Services

Leverage Caprion’s broad range of expertise to meet your specific needs.

  • Target discovery
  • Cell fractionation and organelle isolation
  • Bioanalytical services for PK studies
  • Data analysis

Learn more

In Vitro Diagnostics

Caprion is helping to deliver the promise of personalized medicine by bridging the innovation gap in diagnostics.

  • Diabetes/Metabolic disease
  • Oncology
  • Infectious disease
  • Additional therapeutic indications

Learn more

Strategic Partners & Alliances More

  • Covance

    Caprion is the exclusive biomaker services provider for Covance’s worldwide drug development and commercialisation solutions.

    Covance.com

  • National Institute of Allergy and Infectious Diseases

    NIAID funds the Caprion Clinical Protemoics Center for infectious disease research.

    CCPC.com

  • Québec Consortium for Drug Discovery

    The Québec Consortium for Drug Discovery initiated a projects to develop biomarkers for measurment of early stage diabetes disease and therapy response prediction.

    CQDM.org

  • Québec Consortium for Drug Discovery

    IMMUNECarta Services specializes in integrated, state-of-the-art immune monitoring services for preclinical and clinical studies under GLP/GCLP conditions and standards.

    IMMUNECarta.com

© 2012 Caprion Inc.